Biomarkers and 3D models predicting response to immune checkpoint blockade in head and neck cancer (Review)
Open Access
- 1 June 2022
- journal article
- review article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 61 (1), 1-22
- https://doi.org/10.3892/ijo.2022.5378
Abstract
Immunotherapy has evolved into a powerful tool in the fight against a number of types of cancer, including head and neck squamous cell carcinomas (HNSCC). Although checkpoint inhibition (CPI) has definitely enriched the treatment options for advanced stage HNSCC during the past decade, the percentage of patients responding to treatment is widely varying between 14‑32% in second‑line setting in recurrent or metastatic HNSCC with a sporadic durability. Clinical response and, consecutively, treatment success remain unpredictable in most of the cases. One potential factor is the expression of target molecules of the tumor allowing cancer cells to acquire therapy resistance mechanisms. Accordingly, analyzing and modeling the complexity of the tumor microenvironment (TME) is key to i) stratify subgroups of patients most likely to respond to CPI and ii) to define new combinatorial treatment regimens. Particularly in a heterogeneous disease such as HNSCC, thoroughly studying the interactions and crosstalking between tumor and TME cells is one of the biggest challenges. Sophisticated 3D models are therefore urgently needed to be able to validate such basic science hypotheses and to test novel immuno‑oncologic treatment regimens in consideration of the individual biology of each tumor. The present review will first summarize recent findings on immunotherapy, predictive biomarkers, the role of the TME and signaling cascades eliciting during CPI. Second, it will highlight the significance of current promising approaches to establish HNSCC 3D models for new immunotherapies. The results are encouraging and indicate that data obtained from patient‑specific tumors in a dish might be finally translated into personalized immuno‑oncology.Keywords
This publication has 220 references indexed in Scilit:
- Genomic responses in mouse models poorly mimic human inflammatory diseasesProceedings of the National Academy of Sciences of the United States of America, 2013
- Xenogeneic Graft-versus-Host-Disease in NOD-scid IL-2Rγnull Mice Display a T-Effector Memory PhenotypePLOS ONE, 2012
- Tumor Engraftment in Nude Mice and Enrichment in Stroma- Related Gene Pathways Predict Poor Survival and Resistance to Gemcitabine in Patients with Pancreatic CancerClinical Cancer Research, 2011
- Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinomaJournal of Translational Medicine, 2011
- The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysisBritish Journal of Cancer, 2011
- Newly characterised ex vivo colospheres as a three-dimensional colon cancer cell model of tumour aggressivenessBritish Journal of Cancer, 2009
- Resistance of Athymic Nude Mice to Experimental CutaneousBacillus anthracisInfectionThe Journal of Infectious Diseases, 2009
- Comparison of treatment effects between animal experiments and clinical trials: systematic reviewBMJ, 2006
- 1,026 Experimental treatments in acute strokeAnnals of Neurology, 2006
- Comparative biology of mouse versus human cells: modelling human cancer in miceNature Reviews Cancer, 2003